Cerulyse

Quick links to important sections

Cerulyse

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cerulyse

Property Description
Active ingredient Xylene (Dimethylbenzene)
Form Auricular Solution (Ear Drops)
Pharmacological class Cerumenolytic (S02DC)
Common use Softening and dissolving earwax plugs
Origin Synthetic solvent in an oily base

What Type of Medicine is Cerulyse?

Cerulyse is identified as a pharmaceutical preparation belonging to the cerumenolytic pharmacological class, used for the local management of earwax plugs and cerumen impaction. This classification defines the product's function as an agent that facilitates the chemical and physical breakdown of hardened cerumen within the external ear canal. As an auricular solution, the product is administered strictly via the auricular route and is commonly available as a non-prescription medicine. The official pharmacological classification for this group is S02DC, which is the specific ATC code for cerumenolytics.

Active Ingredient and Oily Solution Form

The single active ingredient defining Cerulyse is Xylene (chemically known as Dimethylbenzene), a synthetic organic solvent. The product is formulated as an oily base solution—often containing emollients like sweet almond oil—which is essential for effective delivery. This specific dosage form, an auricular solution or Ear Drop, is a key feature, ensuring the localized action of Xylene is confined to the site of the earwax impaction. This choice of a single solvent in an oily base differentiates it from dual-action cerumenolytics or preparations that rely on other compounds like carbamide peroxide.

How the Oily Solvent Manages Earwax Plugs

Cerulyse manages impacted earwax through a specific solvent and dispersal action. Xylene's primary role is to chemically dissolve the dense, lipid-rich matrix of the cerumen, causing emulsification and dispersion. The oily vehicle aids this process by contributing a gentle emollient effect, which enhances contact time and further softens the wax. This dual action transforms the typically dry and compacted cerumen into a softer, more fluid state. The practical benefit of Cerulyse is to efficiently prepare the ear canal by liquefying the wax plug, thereby simplifying subsequent manual removal by a healthcare professional.

Regulatory References

  1. NICE Guideline on Earwax Removal

What side effects are possible with Cerulyse?

Possible Side Effects and Safety Information

Cerulyse is an ear solution containing xylene and is generally used to dissolve earwax plugs. Like all medicines, this product can cause side effects, although not everyone experiences them.


Potential Side Effects

The most commonly reported side effects are local reactions within the ear canal. These may include:

  • Irritation or discomfort in the ear.
  • Allergic reactions, which may present as redness or itching.

If the eardrum is not intact (perforated or ruptured), the solution can reach the middle ear, which may lead to undesirable effects in the middle ear structures. If you notice any signs of irritation or a worsening of symptoms after use, discontinue application and consult a healthcare professional.


Contraindications and Safety Warnings

Do not use Cerulyse if:

  • You have a perforation of the eardrum (due to infection or trauma).
  • You have a known allergy or hypersensitivity to xylene or any of the other components (such as alpha-tocopherol acetate, lavender essential oil, or almond oil).

Special Safety Precautions:

It is a precautionary measure that the integrity of your eardrum should be checked by a doctor before administering Cerulyse, especially if there is any doubt about its condition. Use with caution during pregnancy and breastfeeding and only after consulting a healthcare professional.

Cerulyse is generally intended for adults and children over the age of 12.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Cerulyse auricular solution is structured around potential exposure risks, as no cases of overdose have been reported for the product's intended application in the ear.

When to Seek Help

Official guidance mandates that if you have used an amount greater than the intended dose, you must consult a doctor or pharmacist immediately. This regulatory requirement ensures prompt professional assessment for any excessive use.

Documented Manifestations and Serious Outcomes

The regulatory profile addresses the scenario of accidental oral ingestion of the bottle's contents. Systemic Xylene intoxication is considered unlikely due to the small, limited quantity of the solvent present in the product. Despite this, regulatory documentation identifies the potential for a serious complication: the possibility of aspiration pneumonia must be considered following accidental ingestion. Hepatic parenchymal damage is noted to be an unlikely outcome.

Management Procedures

If accidental ingestion occurs, official procedural descriptions for treatment include the use of Gastric Lavage. Overall management of any resulting effects is based on symptomatic and supportive measures, as no specific antidote is documented in the prescribing information.

Therapeutic Uses of Cerulyse

What Cerulyse Treats: Main Uses and Benefits

Cerulyse is primarily used in situations involving symptoms related to physical discomfort in the ear. Its therapeutic aim is to provide support that helps ease the overall burden of symptoms associated with the buildup of cerumen (earwax), which can lead to hearing interference and a feeling of blockage. The use of Cerulyse is relevant in contexts involving earwax plugs where additional symptomatic support is needed. This contributes to easing the overall symptom load during symptomatic phases.

Quick Fact: Relevant for Easing Localized Discomfort


Therapeutic Applications

This medicine is commonly applied in scenarios where symptoms appear suddenly or fluctuate, such as a sensation of fullness or mild hearing difficulty. It is relevant when symptoms create a feeling of heightened local discomfort and interfere with daily functioning. Key uses involve managing conditions presenting with localized or episodic manifestations linked to organ-specific functional stress. The benefit is providing short-term symptomatic assistance that helps address groups of symptoms that create noticeable physiological strain. This supports general well-being during symptomatic phases and may help maintain a sense of stability when symptoms are more noticeable.

Clinical Support Domains

Cerulyse is applied in addressing acute symptom manifestations, providing supportive relief that is relevant for easing symptoms that interfere with routine activities. It is used in clinical contexts where additional symptomatic support is needed, assisting patients to cope more steadily with difficult episodes of temporary auditory disruption.

Regulatory References

  1. Base de Données Publique des Médicaments

Eligibility and Restrictions for Use

Who Can and Cannot Use Cerulyse?

The official regulatory profile for Cerulyse (Xylene auricular solution) establishes strict eligibility requirements based on local anatomical safety and specific population status.

Populations for Whom Use is Contraindicated

Use is absolutely prohibited for two primary populations:

  • Eardrum Damage: Patients with a perforation of the eardrum (tympanic membrane), regardless of infectious or traumatic origin.
  • Allergy: Individuals with a known hypersensitivity to Xylene or any other component (excipient) of the auricular solution.

Age-Related Eligibility

The medicine is generally intended for Adults and Children. While specific minimum age thresholds may vary regionally, the contraindication is not based on age alone. The eardrum integrity rule remains mandatory for all age groups.

Pregnancy and Lactation Eligibility Status

Use is conditional, classified as caution or prudence during pregnancy and lactation. This classification is due to the lack of exploitable clinical data for Cerulyse in these specific populations.

Condition-Specific Eligibility

The only condition-specific eligibility rule relates to the integrity of the eardrum. No specific restrictions regarding use in patients with systemic conditions like hepatic or renal impairment are documented in the official regulatory label.

Summary of Regulatory Classifications

The eligibility profile is defined by absolute contraindications for local anatomical integrity and hypersensitivity, alongside a mandated caution for pregnant and lactating women.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cerulyse is an otic solution containing xylene and is applied topically to the ear canal. Due to its route of administration and localized action, the product's systemic absorption is considered to be minimal. Consequently, official regulatory documents indicate that there are no specifically known or clinically significant interactions documented with other medicinal products. The product's regulatory profile highlights a minimal drug-drug interaction risk.


Interaction Scope and Constraints

Classification Detail (Based on Official Labeling)
Interacting Medicinal Product Categories None explicitly listed
Specific Interacting Medicines None explicitly listed
Mechanistic Basis Not applicable; no known interaction mechanism cited
Interaction Severity Not explicitly classified; no contraindications related to interactions

As a general precaution for all pharmacologic agents, patients are advised to inform their doctor or pharmacist about all prescription and non-prescription medicines, supplements, or herbal products they are currently using, have recently used, or plan to use. This provides a healthcare professional with the complete context needed for safe use, despite the minimal interaction profile of Cerulyse.

Mechanism of Action

Cerulyse is a cerumenolytic solution primarily containing Xylene, which functions as a lipophilic solvent to initiate the chemical dissolution and physical dispersion of the cerumen matrix. This action involves two distinct mechanistic domains that result in localized physicochemical effects within the external ear canal.


Lipophilic Solvent Action and Emulsification

The mechanism initiates by engaging with the lipid components abundant in cerumen, causing their dissolution and dispersion. This solvent action and the subsequent process of emulsification modify the physical structure of the hard, impacted mass. The resulting physicochemical consequence is the reduction of the cerumen plug's viscosity and its transition to a liquid phase.


Physical Disaggregation of Cerumen Matrix

This effect is supported by the overall oily composition of the solution, including Sweet Almond Oil, which acts as a vehicle. This vehicle allows Xylene to fully penetrate the depth of the cerumen plug, assisting in the physical disaggregation of the cerumen matrix by increasing the overall surface area exposure to the solvent. This cascade modifies the physical characteristics of the cerumen, promoting its clearance.

Dosage and Administration Information

How to Use Cerulyse: Administration Guidelines

Cerulyse is an auricular solution, containing Xylene 5 g/100 g, that is administered strictly via auricular instillation (ear drops). The usage pattern is defined as a localized, short-term preparatory course that must precede a subsequent cerumen extraction procedure.

Dosing Schedule and Frequency

The required dosing regimen is differentiated based on the consistency of the earwax plug:

  • For hard, impacted cerumen plugs: The administration involves performing an ear bath—instilling a volume sufficient to fill the ear canal—three times a day. This application pattern is maintained over a short course of 3 to 4 days immediately preceding the extraction.
  • For soft cerumen plugs: The medicine is used only once as an ear bath, approximately 10 minutes before a planned ear washing procedure.

Administration Technique and Constraints

Proper usage requires adherence to specific procedural steps. The bottle must be warmed gently in the palm of the hand prior to instillation to minimize the discomfort of cold liquid in the ear canal. During application, the head must be tilted to the side and held in this position for approximately 10 minutes to ensure the solution saturates the cerumen fully.

The guidelines do not specify altered dosing regimens or adjustments for pediatric patients or other special populations. Any unused solution must be discarded 30 days after the date of first opening the bottle.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Clinical Trials: Evaluating Cerumenolytic Activity

Research on cerumenolytic agents, which are chemical compounds designed to soften earwax (cerumen), has focused on their efficacy in clearing impacted earwax, often in preparation for further manual or irrigation removal procedures. Cerulyse, containing the active ingredient Xylene, is categorized as a cerumenolytic agent.

Efficacy and Wax Clearance

Studies examining ear drops used to soften wax have compared the effectiveness of various ingredients, including aqueous and oil-based preparations. The primary metric evaluated in many trials is the proportion of patients who achieve complete or partial wax clearance, often with the assistance of ear irrigation (syringing).

  • Clearance Rates: Some systematic reviews and meta-analyses suggest that certain chemical cerumenolytics, including compounds like paradichlorobenzene (which is structurally related to ingredients in some formulations) and sodium bicarbonate, are associated with a significantly greater proportion of patients achieving wax clearance following irrigation compared to using plain saline or water.
  • Goal of Treatment: The use of a cerumenolytic agent is intended to break down or soften the hardened earwax plug, potentially lessening the need for irrigation or manual removal, or making those procedures easier and less painful.

Safety and Tolerability Profile

Clinical data focuses on local reactions, as cerumenolytics are generally applied topically within the ear canal.

Observation Area Common Findings Reported in Research
Adverse Events Local irritation, itching, or discomfort in the ear canal.
Contraindications Use of cerumenolytics is generally restricted in the presence of a perforated eardrum or known allergy to the active ingredients.

Design of the Research

Overall, the evidence base for cerumenolytics, including the component Xylene, has been described in academic reviews as heterogeneous in quality and method. Although many substances have been evaluated, large, double-blind, placebo-controlled trials comparing all available strategies (cerumenolytic agents, irrigation, and manual removal) are often limited. Research findings are used to guide standard clinical practice for cerumen management.

Key Studies & References

  1. Clinical Practice Guideline (Update): Earwax (Cerumen Impaction) - American Academy of Otolaryngology–Head and Neck Surgery Foundation
  2. Management of earwax - Hearing loss in adults - NICE Guideline (Chapter 10)
  3. Xylenes (Mixed Isomers) - US Environmental Protection Agency (EPA) Toxicity Profile
  4. Xylene (mixed isomers) - Canadian Centre for Occupational Health and Safety (CCOHS) Safety Profile

Frequently Asked Questions (FAQ)

Common questions about Cerulyse (FAQ)

Q: Is Cerulyse a prescription medicine or can it be bought over the counter?

According to regulatory documents in some regions, this product is classified as an auricular solution generally available for purchase without a prescription. Its status is often described as being non-reimbursed and available at a free price. The ease of access may vary depending on local pharmaceutical regulations.

Q: What is the typical experience of someone who uses Cerulyse?

Official patient instructions suggest gently warming the bottle in the hands before use to help limit any unpleasant cold sensation in the ear canal. It is also described as a normal sensation to feel a blocked or full ear after the solution is administered. If a person experiences significant local irritation or discomfort, official guidance advises consulting a healthcare professional.

Q: Is Cerulyse safe for children to use?

Official product information states that Cerulyse is generally intended for use in adults and children over the age of 12. For use in younger children, official information advises consultation with a healthcare practitioner beforehand. For all age groups, using the product is strictly prohibited if there is a known perforation of the eardrum.

Q: What is the difference between Cerulyse and a simple saline wash?

Cerulyse is described in regulatory documents as a cerumenolytic. This means it is an oily solution containing the active ingredient Xylene that chemically dissolves and emulsifies the earwax plug. A simple saline wash, by contrast, relies on a physical rinsing action alone and does not contain a chemical agent designed to break down the wax.

Q: Is it possible to use Cerulyse too often?

The official documentation defines a specific, short-term usage pattern for Cerulyse (such as a 3 to 4-day course preceding a procedure). Using the product beyond the specified frequency or duration is not covered in the approved regimen. If a person exceeds the defined use, the risk of local irritation or potential negative effects on the middle ear may increase.

Q: Is Cerulyse suitable for people with sensitive skin?

The product label includes local irritation and allergic reactions among the possible side effects, suggesting that it may cause reactions in some individuals. Furthermore, use is strictly prohibited in individuals with known hypersensitivity or allergy to any of the solution’s components, as described in regulatory documents.

Q: Why does the packaging for Cerulyse mention professional use?

The official indication for Cerulyse is defined as dissolving or softening the earwax plug. The primary goal of this preparation is to facilitate the subsequent removal of the wax, which is typically a manual procedure often performed by a healthcare professional.

Q: Does Cerulyse contain alcohol or other irritants?

Official regulatory documents list the active ingredient (Xylene) and the excipients (non-active ingredients) as alpha-tocopherol acetate, lavender essential oil, and almond oil. Alcohol is not listed among these excipients. It is noted that the active ingredient itself is a solvent and is associated with potential local irritation as a side effect.

Q: Are the side effects of Cerulyse generally considered minor?

The documented side effects are primarily local reactions, such as irritation, discomfort, and allergic reactions, which occur at the application site. However, official warnings emphasize that if the eardrum is not intact, the product may potentially cause undesirable effects in the middle ear.

Q: Are there any official reports of adverse events for Cerulyse?

Official patient information provides guidance on how an individual may report an adverse reaction that may be related to the medication. This confirms that a government-regulated pharmacovigilance system is available for collecting and monitoring reports.

Q: How quickly does Cerulyse start to work?

For soft earwax plugs, the official regimen involves administering the solution 10 minutes prior to a planned ear washing procedure. This short time frame indicates that the wax softening and dissolving effect is expected to begin rapidly.

Q: What are the signs that Cerulyse is starting to take effect?

The intended effect of the solution is the dissolution and softening of the hardened earwax plug. This action is officially described as facilitating the subsequent physical removal of the cerumen by a healthcare practitioner.

Q: Can Cerulyse be used for uses other than what is listed on the packaging?

The official indication, as defined by regulatory documents, is strictly limited to dissolving earwax plugs in the ear canal to facilitate their subsequent removal. The product is not intended for any other purposes.

Q: Are there different concentrations of Cerulyse available?

Official regulatory documents consistently define the product as a single concentration: a 5 g/100 g Xylene auricular solution. This indicates that a single standard strength is available for use.

Q: Is there any evidence about Cerulyse and long-term use?

Official prescribing information defines the duration of use as a short course, intended only to prepare the ear for a specific procedure (up to 3 or 4 days). The regulatory label does not contain information or evidence regarding long-term or chronic use of the solution.

Q: Does Cerulyse contain a preservative?

Official documentation lists the non-active ingredients as alpha-tocopherol acetate, lavender essential oil, and almond oil. An explicit ingredient classified solely as a preservative is not named among these listed excipients.

How should Cerulyse be stored and disposed of?

How to Store and Dispose of Cerulyse

Official regulatory labeling dictates specific conditions for storing and disposing of Cerulyse auricular solution to maintain its stability and integrity.

Storage Requirements

  • Temperature: Store the product at a temperature not exceeding 25 C.
  • Container: The medicine must be stored in its original container (a brown glass bottle).
  • Child Safety: It is mandatory to keep Cerulyse out of the sight and out of the reach of children.

Stability and Disposal

  • Post-Opening Use: Once the bottle has been opened for the first time, the solution must be used within 30 days.
  • Disposal: Any unused medicinal product or waste material resulting from the use of Cerulyse must be disposed of in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cerulyse found in:

A-Z Index: